CD4 and diabetes mellitus: Notably, NOD mice genetically engineered for deficiency of mature B cells do not develop diabetes, and this lack of disease progression is associated with dramatic reductions in islet antigen-specific CD4+ and CD8+ T cells in secondary lymphoid organs and insulitic lesions.